in

Semaglutide Rocketing Past Statins as Millions Eligible

Source link : https://www.newshealth.biz/health-news/semaglutide-rocketing-past-statins-as-millions-eligible/

About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, said authors of a new study. Currently, statins are the most commonly prescribed medication for American adults, with some 192 million prescriptions written in 2022, according to one estimate. The authors of a […]

Author : News Health

Publish date : 2024-11-27 12:15:15

Copyright for syndicated content belongs to the linked Source.

EU countries ready to fund defence products despite US use restrictions – EURACTIV

Zhou: Ferrari is “actually eager about me” for 2025 F1 season